The period of untreated psychosis before treatment initiation: a qualitative study of family members' perspectives.

Department of Behavioral Sciences and Health Education, Rollins School of Public Health of Emory University, Atlanta, GA 30322, USA.
Comprehensive psychiatry (Impact Factor: 2.26). 11/2008; 49(6):530-6. DOI: 10.1016/j.comppsych.2008.02.010
Source: PubMed

ABSTRACT This study used a qualitative research methodology to explore common themes pertaining to the period of untreated psychosis before treatment initiation in hospitalized, urban, African American, first-episode psychosis patients.
Twelve family members of 10 patients were interviewed at length to gather detailed narrative accounts of factors related to untreated psychosis and treatment delay. Using qualitative analysis, verbatim transcripts were reviewed by 2 researchers to identify prominent themes useful for generating future research hypotheses.
Four themes emerged as informative of the period of untreated psychosis before treatment initiation: (1) misattribution of symptoms or problem behaviors (eg, depression, drug use, and adolescent rebellion), (2) positive symptoms causing unusual or dangerous behaviors that served as a catalyst for initiating treatment, (3) views about personal autonomy of an adult or nearly adult patient, and (4) system-level factors (eg, unaffordability of health care and inefficiency on the part of health care providers).
Family members encountered numerous barriers when seeking treatment, including their own misattributions, the nature of the patient's symptoms, financial issues, and system-level delays. The themes uncovered in this formative analysis merit further exploration with additional qualitative and quantitative research.


Available from: Nancy J Thompson, Mar 24, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives This paper reports on a qualitative exploration of the reasons for differences in pathways to care and duration of untreated psychosis (DUP) in the African, Caribbean and European (ACE) Pathways to Care study from the perspective of respondents to the study and their families. Setting Ontario, Canada. Participants Thirty-four participants in total. Twenty-five young people who had experienced a first episode of psychosis and nine family members. Participants were part of the ACE Pathways to Care study. Design We implemented six focus groups. Furthermore, we implemented four in-depth interviews with two African-origin young women, one Caribbean-origin woman, and one European-origin woman with lived experience of psychosis. Results Factors that influenced help-seeking delays across the three groups were: personal awareness of symptoms, family members’ knowledge of psychotic symptoms and knowledge of mental health services. Youth and their family members described how stigma played a key role in pathways to care by stopping them from asking for help. The way in which stigma operated on the three groups’ members, from feeling ashamed to feeling guilty for their mental illnesses, helped to explain differences in DUP between the groups. Guilt feelings emerged as a prominent theme among members from the African and Caribbean groups and it was not discussed in the European focus group. Delay in entering into first-episode psychosis programmes was also influenced by the stigma perceived by young people in healthcare settings. This had an impact on the therapeutic relationships, disclosure of symptoms and overall trust in the healthcare system. Conclusions The findings of this paper suggest that stigma, especially internalised stigma, may operate in different ways in European-origin, African-origin and Caribbean-origin groups. These findings could inform the development of more equitable services for people in early stages of psychosis.
    BMJ Open 01/2015; 5(1):e006562. DOI:10.1136/bmjopen-2014-006562 · 2.06 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To synthesise the evidence on implementing family involvement in the treatment of patients with psychosis with a focus on barriers, problems and facilitating factors.
    BMJ Open 10/2014; 4(10):e006108. DOI:10.1136/bmjopen-2014-006108 · 2.06 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is accumulating epidemiological evidence of cross-ethnic differences in relation to schizophrenia’s incidence and prevalence. However, there is a dearth of information about the manifestations of cultural differences of schizophrenia’s symptoms. This thesis aims to bridge the gap in the knowledge on the relationship between cross-cultural differences and schizophrenia. Throughout this thesis, I explore the similarities and dissimilarities of the content of clinical manifestation across cultures. I also examine and further develop epidemiological and clinical issues. First, I perform a qualitative systematic review which includes 26 publications. This is followed by findings from a statistical analysis of a mental health population of 860 patients in Brent, North London. Lastly, I report on results from a semi-structured mental health questionnaire that was devised and disseminated to 48 mental health professionals in London. Results indicate that for ethnic groups that experience a higher incidence of schizophrenia they also tend to display more positive or first rank symptoms. These ethnic groups that experience higher schizophrenia also belong to cultures that culturally legitimise an externalization of their distress. On the other hand, it was found that cultures that internalize their distress experience lower schizophrenia incidence. My research further demonstrates that schizophrenia’s interpretations are heavily reliant on the diagnosers’ own cultural background, and on the degree to which the externalization of a symptom is tolerable in that context. Evidence of intra-cultural diversity in the clinical settings furthermore posits future recommendations of the importance of achieving higher cultural competence.
    10/2012, Degree: PhD Psychology Research, Supervisor: Dany Nobus